Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Remibrutinib Inhibits Neuroinflammation Driven by B Cells and Myeloid Cells in Preclinical Models of Multiple Sclerosis

Author:Kieseier, Bernd   Cenni, Bruno   Nuesslein-Hildesheim, Barbara   Ferrero, Enrico   Huck, Catherine   Eichlisberger, Denis   Ziehn, Marina   

Session Name:P2: MS Immunology and Basic Science  

Topic:MS and Inflammatory Disease  

Program Number:P2.013  

Author Institution:Novartis Pharma AG  Novartis Institutes for Biomedical Research  

Remibrutinib, a Novel Bruton’s Tyrosine Kinase Inhibitor, Exhibits Improved Target Selectivity and Potency In Vitro

Author:Kieseier, Bernd   Cenni, Bruno   Pulz, Robert   Angst, Daniela   Eichlisberger, Denis   Ziehn, Marina   

Session Name:P8: MS Therapeutics 2  

Topic:MS and Inflammatory Disease  

Program Number:P8.003  

Author Institution:Novartis Pharma AG  Novartis Institutes for Biomedical Research